Join Growin Stock Community!
Back to PFE.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

ev-to-sales-chart

PFE EV/Sales

EV/Sales

Browsing restrictions can be lifted for a fee.

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of Q4'25, Pfizer's EV/Sales ratio stands at 8.06, marking the lowest point in the observed period from Q1'23 to Q4'25. This latest data point reflects a significant decline from the previous quarter's value of 11.92. Over the period from Q1'23 to Q4'25, the EV/Sales ratio for Pfizer has demonstrated considerable volatility, peaking at 20.82 in Q2'23 before trending downward. Notable inflection points include sharp drops after Q2'23 and again from Q2'25 to Q4'25, indicating a consistent downward trend in valuation relative to sales, especially in the latter half of the period.